Global Renal Denervation Market (RDN) is anticipated to touch USD 2,850 million at a whopping 40.4% CAGR during the estimated years (2018-2023).
Renal denervation is a minimally invasive method that helps to treat resistant hypertension. This is a condition where high blood pressure does not respond to medication.
Some of the common causes associated to renal hypertension include abnormality in the hormone which control blood pressure, sleep problems especially obstructive sleep apnea, excessive consumption of alcohol, obesity and artery-clogging plaque accumulation in the blood vessels. The RDN procedure utilizes radiofrequency ablation that helps to burn the nerves present in the renal arteries that reduces the nerve activity and this in turn decreases blood pressure. This procedure aids to cut down blood pressure which is difficult to control through medication.
Get Free Sample at https://www.marketresearchfuture.com/sample_request/6712
Thus, this reduces the risk of kidney disease, heart failure, heart attack, stroke and death significantly. Besides renal denervation may also reduce the intake of medication that a patient may require to take for keeping their blood pressure in check. The best part, this technique is minimally invasive, safe and above will not leave behind any implants.
MRFR report offers a complete segmental analysis of the renal denervation market on the basis of product, technology and end use.
- Based on product, it is segmented into Iberis, Paradise, EnligHTN, Vessix (V2), Symplicity and others. Of these, Symplicity will have the maximum share in the market and hold its position during the estimated years. However, Paradise is expected to grow at the fastest pace.
- Based on technology, the renal denervation market is segmented into micro-infusion, ultrasound, radiofrequency and others. Of these, radiofrequency will dominate the renal denervation market during the estimated years. With regards to growth rate, eclipsing ultrasound is presently the largest segment in the market.
- Based on end user, it is segmented into surgical centers, ambulatory, clinics, hospitals and others. Of these, hospitals will lead the renal denervation market during the estimated years followed by ambulatory that is projected to expand at the fastest pace.
Leading players profiled in the renal denervation market include Terumo, Sound Intervention, Kona Medical, Cordis, Cardiosonic, St Jude Medical, ReCor Medical, Medtronic, Boston Scientific and others.
Nov 2018– Leading global medical technology, solutions and services provider, Medtronic confirmed that FDA has given the green signal to the company for proceeding with the investigational device exemption trial of the renal denervation system to treat hypertension in those that are already having antihypertensive medications.
Brows Complete Premium Research report with Respective TOC at https://www.marketresearchfuture.com/reports/renal-denervation-market-6712
On the contrary, pain and patient discomfort coupled with strict regulatory guidelines are factors that may impede the growth of the renal denervation market during the estimated years.
By region, the renal denervation market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Rest of the World. Of these,
Europe will spearhead the market during the estimated years owing to the region’s strong research infrastructure, rising development of advanced renal denervation devices and rising incidence of drug-resistant hypertension.
In the APAC region, the renal denervation market is likely to have a major share owing to steady improvement within the healthcare infrastructure and growing incidence of hypertension.
In North America, the renal denervation market will have a promising growth owing to the increasing filings for FDA approvals in the US. Increasing prevalence of uncontrolled hypertension is a key factor that is propelling the growth of the market here.
Inquire for Exclusive Discount at https://www.marketresearchfuture.com/check-discount/6712
There are numerous factors that is driving the growth of the renal denervation market. These factors according to MRFR (Market Research Future) report include increasing incidence of blood pressure and hypertension, cost effective technique, improvement in healthcare infrastructure especially in developing countries, rising geriatric population, rising number of clinical trials in order to validate renal denervation’s clinical efficacy, clinal benefits particularly faster recovery time coupled with minimal complications, growing awareness amid people, increasing need for minimally invasive procedures, support from the government and risk minimization.
About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312